Comorbidities in children with cerebral palsy: a single-centre cross-sectional hospital-based study from India

Maya Viswanath1, Ruchika Jha1, Ankita Dilip Gambhirao1

  • 1Department of Pediatrics, Armed Forces Medical College, Pune, Maharashtra, India.

BMJ Open
|July 10, 2023
PubMed

Insights

Children with cerebral palsy (CP) experience a high burden of comorbidities, particularly visual and cognitive impairments. Early identification and management of these co-occurring conditions are crucial for improving outcomes in children with CP.

Area of Science:

  • Neurology
  • Pediatrics
  • Public Health

Background:

  • Cerebral palsy (CP) is a complex neurological disorder affecting children.
  • Comorbidities are common in children with CP, impacting their overall health and development.
  • Understanding the spectrum and characteristics of these co-occurring impairments is essential for comprehensive care.

Purpose of the Study:

  • To describe the prevalence of comorbidities in children diagnosed with cerebral palsy (CP).
  • To identify characteristics associated with different types of impairments in children with CP.
  • To inform strategies for managing the multifaceted needs of children with CP.

Main Methods:

  • A cross-sectional study was conducted at a tertiary care referral center in India.
  • 384 children aged 2-18 years with confirmed CP diagnosis were enrolled.
  • Data collected included risk factors, clinical evaluations, and investigations (neuroimaging, genetic/metabolic workup).

Main Results:

  • High prevalence of comorbidities was observed, including visual impairment (93.2%), cognitive impairment (88.8%), and epilepsy (64%).
  • Drug-resistant epilepsy affected 42.4% of participants.
  • Hemiparetic and diplegic CP, along with lower Gross Motor Function Classification System scores, predicted fewer co-occurring impairments.

Conclusions:

  • Children with CP face a significant burden of comorbidities that escalate with functional impairment.
  • Preventive measures targeting CP risk factors are needed.
  • Organized resources are required for timely identification and management of co-occurring impairments in CP.
Abstract